Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

C. X. Ma, M. J. Ellis

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)266-267
Number of pages2
JournalBreast Diseases
Volume21
Issue number3
DOIs
StatePublished - 2010

Cite this